nodes	percent_of_prediction	percent_of_DWPC	metapath
Mecamylamine—Fibrosis—Fluorouracil—urinary bladder cancer	0.0636	0.0636	CcSEcCtD
Mecamylamine—Fibrosis—Cisplatin—urinary bladder cancer	0.0603	0.0603	CcSEcCtD
Mecamylamine—Urinary retention—Valrubicin—urinary bladder cancer	0.0438	0.0438	CcSEcCtD
Mecamylamine—Pulmonary oedema—Mitomycin—urinary bladder cancer	0.0389	0.0389	CcSEcCtD
Mecamylamine—Fibrosis—Methotrexate—urinary bladder cancer	0.0331	0.0331	CcSEcCtD
Mecamylamine—Ileus—Thiotepa—urinary bladder cancer	0.0311	0.0311	CcSEcCtD
Mecamylamine—Pulmonary oedema—Thiotepa—urinary bladder cancer	0.0196	0.0196	CcSEcCtD
Mecamylamine—Vision blurred—Mitomycin—urinary bladder cancer	0.018	0.018	CcSEcCtD
Mecamylamine—Syncope—Mitomycin—urinary bladder cancer	0.0171	0.0171	CcSEcCtD
Mecamylamine—Loss of consciousness—Mitomycin—urinary bladder cancer	0.0168	0.0168	CcSEcCtD
Mecamylamine—Pulmonary oedema—Gemcitabine—urinary bladder cancer	0.0165	0.0165	CcSEcCtD
Mecamylamine—Asthenia—Valrubicin—urinary bladder cancer	0.0162	0.0162	CcSEcCtD
Mecamylamine—Shock—Mitomycin—urinary bladder cancer	0.0153	0.0153	CcSEcCtD
Mecamylamine—Urinary retention—Thiotepa—urinary bladder cancer	0.0152	0.0152	CcSEcCtD
Mecamylamine—Dizziness—Valrubicin—urinary bladder cancer	0.015	0.015	CcSEcCtD
Mecamylamine—Anorexia—Mitomycin—urinary bladder cancer	0.0149	0.0149	CcSEcCtD
Mecamylamine—Vomiting—Valrubicin—urinary bladder cancer	0.0144	0.0144	CcSEcCtD
Mecamylamine—Decreased appetite—Mitomycin—urinary bladder cancer	0.0136	0.0136	CcSEcCtD
Mecamylamine—Nausea—Valrubicin—urinary bladder cancer	0.0135	0.0135	CcSEcCtD
Mecamylamine—Fatigue—Mitomycin—urinary bladder cancer	0.0135	0.0135	CcSEcCtD
Mecamylamine—Ileus—Epirubicin—urinary bladder cancer	0.0125	0.0125	CcSEcCtD
Mecamylamine—Ileus—Doxorubicin—urinary bladder cancer	0.0116	0.0116	CcSEcCtD
Mecamylamine—Orthostatic hypotension—Cisplatin—urinary bladder cancer	0.0114	0.0114	CcSEcCtD
Mecamylamine—Asthenia—Mitomycin—urinary bladder cancer	0.0112	0.0112	CcSEcCtD
Mecamylamine—Dizziness—Mitomycin—urinary bladder cancer	0.0103	0.0103	CcSEcCtD
Mecamylamine—Glossitis—Methotrexate—urinary bladder cancer	0.0103	0.0103	CcSEcCtD
Mecamylamine—Vomiting—Mitomycin—urinary bladder cancer	0.00992	0.00992	CcSEcCtD
Mecamylamine—Glossitis—Epirubicin—urinary bladder cancer	0.00961	0.00961	CcSEcCtD
Mecamylamine—Nausea—Mitomycin—urinary bladder cancer	0.00927	0.00927	CcSEcCtD
Mecamylamine—Vision blurred—Thiotepa—urinary bladder cancer	0.00906	0.00906	CcSEcCtD
Mecamylamine—Glossitis—Doxorubicin—urinary bladder cancer	0.00889	0.00889	CcSEcCtD
Mecamylamine—Pulmonary oedema—Methotrexate—urinary bladder cancer	0.00842	0.00842	CcSEcCtD
Mecamylamine—Convulsion—Thiotepa—urinary bladder cancer	0.00833	0.00833	CcSEcCtD
Mecamylamine—Pulmonary oedema—Epirubicin—urinary bladder cancer	0.00788	0.00788	CcSEcCtD
Mecamylamine—Vision blurred—Fluorouracil—urinary bladder cancer	0.00749	0.00749	CcSEcCtD
Mecamylamine—Anorexia—Thiotepa—urinary bladder cancer	0.00748	0.00748	CcSEcCtD
Mecamylamine—Pulmonary oedema—Doxorubicin—urinary bladder cancer	0.00729	0.00729	CcSEcCtD
Mecamylamine—Vision blurred—Cisplatin—urinary bladder cancer	0.0071	0.0071	CcSEcCtD
Mecamylamine—Tremor—Cisplatin—urinary bladder cancer	0.00706	0.00706	CcSEcCtD
Mecamylamine—Paraesthesia—Thiotepa—urinary bladder cancer	0.00705	0.00705	CcSEcCtD
Mecamylamine—Convulsion—Fluorouracil—urinary bladder cancer	0.00689	0.00689	CcSEcCtD
Mecamylamine—Decreased appetite—Thiotepa—urinary bladder cancer	0.00682	0.00682	CcSEcCtD
Mecamylamine—Fatigue—Thiotepa—urinary bladder cancer	0.00676	0.00676	CcSEcCtD
Mecamylamine—Constipation—Thiotepa—urinary bladder cancer	0.00671	0.00671	CcSEcCtD
Mecamylamine—Convulsion—Cisplatin—urinary bladder cancer	0.00653	0.00653	CcSEcCtD
Mecamylamine—Anorexia—Gemcitabine—urinary bladder cancer	0.00629	0.00629	CcSEcCtD
Mecamylamine—Anorexia—Fluorouracil—urinary bladder cancer	0.00619	0.00619	CcSEcCtD
Mecamylamine—Loss of consciousness—Etoposide—urinary bladder cancer	0.00607	0.00607	CcSEcCtD
Mecamylamine—Convulsion—Etoposide—urinary bladder cancer	0.00598	0.00598	CcSEcCtD
Mecamylamine—Paraesthesia—Gemcitabine—urinary bladder cancer	0.00593	0.00593	CcSEcCtD
Mecamylamine—Orthostatic hypotension—Epirubicin—urinary bladder cancer	0.00587	0.00587	CcSEcCtD
Mecamylamine—Anorexia—Cisplatin—urinary bladder cancer	0.00586	0.00586	CcSEcCtD
Mecamylamine—Paraesthesia—Fluorouracil—urinary bladder cancer	0.00583	0.00583	CcSEcCtD
Mecamylamine—Decreased appetite—Gemcitabine—urinary bladder cancer	0.00574	0.00574	CcSEcCtD
Mecamylamine—Fatigue—Gemcitabine—urinary bladder cancer	0.00569	0.00569	CcSEcCtD
Mecamylamine—Constipation—Gemcitabine—urinary bladder cancer	0.00564	0.00564	CcSEcCtD
Mecamylamine—Decreased appetite—Fluorouracil—urinary bladder cancer	0.00564	0.00564	CcSEcCtD
Mecamylamine—Asthenia—Thiotepa—urinary bladder cancer	0.00563	0.00563	CcSEcCtD
Mecamylamine—Paraesthesia—Cisplatin—urinary bladder cancer	0.00552	0.00552	CcSEcCtD
Mecamylamine—Erectile dysfunction—Methotrexate—urinary bladder cancer	0.00547	0.00547	CcSEcCtD
Mecamylamine—Orthostatic hypotension—Doxorubicin—urinary bladder cancer	0.00543	0.00543	CcSEcCtD
Mecamylamine—Anorexia—Etoposide—urinary bladder cancer	0.00537	0.00537	CcSEcCtD
Mecamylamine—Decreased appetite—Cisplatin—urinary bladder cancer	0.00535	0.00535	CcSEcCtD
Mecamylamine—Dizziness—Thiotepa—urinary bladder cancer	0.00519	0.00519	CcSEcCtD
Mecamylamine—Paraesthesia—Etoposide—urinary bladder cancer	0.00506	0.00506	CcSEcCtD
Mecamylamine—Vomiting—Thiotepa—urinary bladder cancer	0.00499	0.00499	CcSEcCtD
Mecamylamine—Decreased appetite—Etoposide—urinary bladder cancer	0.0049	0.0049	CcSEcCtD
Mecamylamine—Fatigue—Etoposide—urinary bladder cancer	0.00486	0.00486	CcSEcCtD
Mecamylamine—Constipation—Etoposide—urinary bladder cancer	0.00482	0.00482	CcSEcCtD
Mecamylamine—Asthenia—Gemcitabine—urinary bladder cancer	0.00474	0.00474	CcSEcCtD
Mecamylamine—Nausea—Thiotepa—urinary bladder cancer	0.00466	0.00466	CcSEcCtD
Mecamylamine—Asthenia—Cisplatin—urinary bladder cancer	0.00441	0.00441	CcSEcCtD
Mecamylamine—Dizziness—Fluorouracil—urinary bladder cancer	0.00429	0.00429	CcSEcCtD
Mecamylamine—Vomiting—Gemcitabine—urinary bladder cancer	0.0042	0.0042	CcSEcCtD
Mecamylamine—Vomiting—Fluorouracil—urinary bladder cancer	0.00413	0.00413	CcSEcCtD
Mecamylamine—Asthenia—Etoposide—urinary bladder cancer	0.00404	0.00404	CcSEcCtD
Mecamylamine—Nausea—Gemcitabine—urinary bladder cancer	0.00392	0.00392	CcSEcCtD
Mecamylamine—Vomiting—Cisplatin—urinary bladder cancer	0.00391	0.00391	CcSEcCtD
Mecamylamine—Vision blurred—Methotrexate—urinary bladder cancer	0.0039	0.0039	CcSEcCtD
Mecamylamine—Nausea—Fluorouracil—urinary bladder cancer	0.00385	0.00385	CcSEcCtD
Mecamylamine—Dizziness—Etoposide—urinary bladder cancer	0.00373	0.00373	CcSEcCtD
Mecamylamine—Nausea—Cisplatin—urinary bladder cancer	0.00365	0.00365	CcSEcCtD
Mecamylamine—Vision blurred—Epirubicin—urinary bladder cancer	0.00365	0.00365	CcSEcCtD
Mecamylamine—Convulsion—Methotrexate—urinary bladder cancer	0.00358	0.00358	CcSEcCtD
Mecamylamine—Vomiting—Etoposide—urinary bladder cancer	0.00358	0.00358	CcSEcCtD
Mecamylamine—Syncope—Epirubicin—urinary bladder cancer	0.00347	0.00347	CcSEcCtD
Mecamylamine—Loss of consciousness—Epirubicin—urinary bladder cancer	0.0034	0.0034	CcSEcCtD
Mecamylamine—Vision blurred—Doxorubicin—urinary bladder cancer	0.00338	0.00338	CcSEcCtD
Mecamylamine—Convulsion—Epirubicin—urinary bladder cancer	0.00335	0.00335	CcSEcCtD
Mecamylamine—Nausea—Etoposide—urinary bladder cancer	0.00335	0.00335	CcSEcCtD
Mecamylamine—Anorexia—Methotrexate—urinary bladder cancer	0.00322	0.00322	CcSEcCtD
Mecamylamine—Syncope—Doxorubicin—urinary bladder cancer	0.00321	0.00321	CcSEcCtD
Mecamylamine—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.00315	0.00315	CcSEcCtD
Mecamylamine—Shock—Epirubicin—urinary bladder cancer	0.00311	0.00311	CcSEcCtD
Mecamylamine—Convulsion—Doxorubicin—urinary bladder cancer	0.0031	0.0031	CcSEcCtD
Mecamylamine—Paraesthesia—Methotrexate—urinary bladder cancer	0.00303	0.00303	CcSEcCtD
Mecamylamine—Anorexia—Epirubicin—urinary bladder cancer	0.00301	0.00301	CcSEcCtD
Mecamylamine—Decreased appetite—Methotrexate—urinary bladder cancer	0.00293	0.00293	CcSEcCtD
Mecamylamine—Fatigue—Methotrexate—urinary bladder cancer	0.00291	0.00291	CcSEcCtD
Mecamylamine—Shock—Doxorubicin—urinary bladder cancer	0.00288	0.00288	CcSEcCtD
Mecamylamine—Paraesthesia—Epirubicin—urinary bladder cancer	0.00284	0.00284	CcSEcCtD
Mecamylamine—Anorexia—Doxorubicin—urinary bladder cancer	0.00279	0.00279	CcSEcCtD
Mecamylamine—Decreased appetite—Epirubicin—urinary bladder cancer	0.00275	0.00275	CcSEcCtD
Mecamylamine—Fatigue—Epirubicin—urinary bladder cancer	0.00272	0.00272	CcSEcCtD
Mecamylamine—Constipation—Epirubicin—urinary bladder cancer	0.0027	0.0027	CcSEcCtD
Mecamylamine—Paraesthesia—Doxorubicin—urinary bladder cancer	0.00262	0.00262	CcSEcCtD
Mecamylamine—Decreased appetite—Doxorubicin—urinary bladder cancer	0.00254	0.00254	CcSEcCtD
Mecamylamine—Fatigue—Doxorubicin—urinary bladder cancer	0.00252	0.00252	CcSEcCtD
Mecamylamine—Constipation—Doxorubicin—urinary bladder cancer	0.0025	0.0025	CcSEcCtD
Mecamylamine—Asthenia—Methotrexate—urinary bladder cancer	0.00242	0.00242	CcSEcCtD
Mecamylamine—Asthenia—Epirubicin—urinary bladder cancer	0.00227	0.00227	CcSEcCtD
Mecamylamine—Dizziness—Methotrexate—urinary bladder cancer	0.00223	0.00223	CcSEcCtD
Mecamylamine—Vomiting—Methotrexate—urinary bladder cancer	0.00215	0.00215	CcSEcCtD
Mecamylamine—Asthenia—Doxorubicin—urinary bladder cancer	0.0021	0.0021	CcSEcCtD
Mecamylamine—Dizziness—Epirubicin—urinary bladder cancer	0.00209	0.00209	CcSEcCtD
Mecamylamine—Vomiting—Epirubicin—urinary bladder cancer	0.00201	0.00201	CcSEcCtD
Mecamylamine—Nausea—Methotrexate—urinary bladder cancer	0.00201	0.00201	CcSEcCtD
Mecamylamine—Dizziness—Doxorubicin—urinary bladder cancer	0.00193	0.00193	CcSEcCtD
Mecamylamine—Nausea—Epirubicin—urinary bladder cancer	0.00188	0.00188	CcSEcCtD
Mecamylamine—Vomiting—Doxorubicin—urinary bladder cancer	0.00186	0.00186	CcSEcCtD
Mecamylamine—Nausea—Doxorubicin—urinary bladder cancer	0.00174	0.00174	CcSEcCtD
